News
MyChesCo on MSN6d
Ocugen Strengthens Leadership and Advisory Board as It Targets Three Biologics Filings in Three Years
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has expanded its Retina Scientific Advisory Board (SAB) and executive leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback